Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
CA Stock MarketDetailed Quotes
Quantum BioPharma Ltd (QNTM)
- 9.940
- -0.060-0.60%
15min DelayMarket Closed Jan 15 11:22 ET
38.20MMarket Cap-0.75P/E (TTM)
9.940High9.570Low733Volume9.570Open10.000Prev Close7.07KTurnover52.00052wk High0.02%Turnover Ratio3.84MShares4.20052wk Low-13.295EPS TTM35.76MFloat Cap52.000Historical HighLossP/E (Static)3.60MShs Float3.900Historical Low-18.871EPS LYR3.70%Range %--Dividend TTM3.18P/B1Lot Size--Div Yield TTM
Quantum BioPharma Ltd (QNTM) Balance Sheet
Quarterly+Annual
YOY
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -83.61%1.08M | -54.08%1.53M | 69.31%3.54M | 104.89%7.2M | 104.89%7.2M | 50.89%6.61M | -41.42%3.33M | -77.39%2.09M | -79.34%3.51M | -79.34%3.51M |
| -Cash and cash equivalents | -85.71%445.94K | -54.71%1.5M | 164.49%3.52M | 117.47%6M | 117.47%6M | -14.14%3.12M | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M | -83.76%2.76M |
| -Short term investments | -81.73%636.76K | 40.46%30.79K | -97.25%20.87K | 59.02%1.2M | 59.02%1.2M | 368.48%3.49M | 98.35%21.92K | 3,175.62%760.14K | 3,160.74%756.1K | 3,160.74%756.1K |
| Receivables | -58.57%2.94M | -50.75%3.23M | -50.03%3.41M | -48.67%3.81M | -48.67%3.81M | 56.80%7.09M | 124.59%6.56M | 953.05%6.83M | 1,881.09%7.42M | 1,881.09%7.42M |
| -Loans receivable | -59.07%2.86M | -53.08%3.04M | -54.69%3.02M | -52.25%3.43M | -52.25%3.43M | --6.98M | 178.86%6.48M | --6.66M | --7.19M | --7.19M |
| -Accrued interest receivable | -99.44%162 | -58.27%164 | -99.37%156 | -98.99%156 | -98.99%156 | 426.59%28.85K | -92.60%393 | --24.78K | -83.68%15.51K | -83.68%15.51K |
| -Taxes receivable | 10.87%78.14K | 57.87%130.67K | 21.38%167.61K | 75.37%367.48K | 75.37%367.48K | -65.63%70.48K | -77.01%82.77K | -66.88%138.09K | -24.98%209.55K | -24.98%209.55K |
| -Other receivables | ---- | 1,584.04%62.36K | 6,005.32%226.08K | 90.17%7.04K | 90.17%7.04K | -99.88%4.87K | 0.00%3.7K | -54.10%3.7K | --3.7K | --3.7K |
| Inventory | --77.62K | --76.87K | --93.86K | --117.24K | --117.24K | ---- | ---- | ---- | --0 | --0 |
| Prepaid assets | -73.86%39.29K | 247.50%453.22K | -47.14%144.35K | -55.58%69.04K | -55.58%69.04K | -56.85%150.33K | -74.05%130.42K | -67.39%273.1K | -67.08%155.41K | -67.08%155.41K |
| Other current assets | --5.21M | --5.05M | --2.74M | --861.23K | --861.23K | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -32.51%9.34M | 3.21%10.34M | 8.06%9.93M | 8.73%12.05M | 8.73%12.05M | 49.72%13.84M | 10.05%10.02M | -14.36%9.19M | -37.90%11.09M | -37.90%11.09M |
| Non current assets | ||||||||||
| Net PPE | 38.95%190.76K | 212.06%228.17K | 4.01%109.32K | 8.27%130.38K | 8.27%130.38K | 1.11%137.28K | -58.81%73.12K | -52.57%105.1K | -53.85%120.42K | -53.85%120.42K |
| -Gross PPE | 38.95%190.76K | 212.06%228.17K | 4.01%109.32K | 8.27%130.38K | 8.27%130.38K | 1.11%137.28K | -58.81%73.12K | -52.57%105.1K | -53.85%120.42K | -53.85%120.42K |
| Investments and advances | --0 | --0 | -62.33%2.22K | -63.23%2.22K | -63.23%2.22K | -94.58%5.93K | -98.94%5.85K | -99.09%5.9K | -99.27%6.05K | -99.27%6.05K |
| -Financial asset investment | ---- | ---- | ---- | -63.23%2.22K | -63.23%2.22K | ---- | ---- | ---- | --6.05K | --6.05K |
| -Including:Available-for-sale securities | ---- | ---- | ---- | -63.23%2.22K | -63.23%2.22K | ---- | ---- | ---- | --6.05K | --6.05K |
| -Other investment | --0 | --0 | -62.33%2.22K | ---- | ---- | -94.58%5.93K | -98.94%5.85K | -99.09%5.9K | ---- | ---- |
| Non current accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -88.04%885.59K | ---- | ---- |
| Non current note receivables | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -87.79%907.37K | -87.79%907.37K |
| Goodwill and other intangible assets | -8.35%4.62M | -8.17%4.73M | -8.01%4.83M | -7.88%4.93M | -7.88%4.93M | -7.72%5.04M | -7.58%5.15M | -49.85%5.25M | -55.52%5.36M | -55.52%5.36M |
| -Other intangible assets | -8.35%4.62M | -8.17%4.73M | -8.01%4.83M | -7.88%4.93M | -7.88%4.93M | -7.72%5.04M | -7.58%5.15M | -49.85%5.25M | -55.52%5.36M | -55.52%5.36M |
| Total non current assets | -7.20%4.81M | -5.20%4.95M | -20.90%4.94M | -20.71%5.07M | -20.71%5.07M | -46.54%5.18M | -57.53%5.22M | -66.68%6.25M | -68.92%6.39M | -68.92%6.39M |
| Total assets | -25.61%14.15M | 0.33%15.3M | -3.66%14.87M | -2.03%17.12M | -2.03%17.12M | 0.45%19.03M | -28.78%15.25M | -47.63%15.44M | -54.51%17.47M | -54.51%17.47M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | 585.50%2.56M | 262.31%2.27M | 105.23%1.28M | 143.20%824.92K | 143.20%824.92K | 2.80%373.02K | 53.33%625.2K | 41.05%623.8K | -29.10%339.2K | -29.10%339.2K |
| -Current debt | 700.30%2.41M | 242.54%2.11M | 107.51%1.24M | 156.58%771.14K | 156.58%771.14K | 0.00%300.55K | 104.81%615.56K | 99.60%599.91K | 0.00%300.55K | 0.00%300.55K |
| -Current capital lease obligation | 109.45%151.8K | 1,525.20%156.57K | 47.98%35.36K | 39.15%53.78K | 39.15%53.78K | 16.32%72.48K | -91.01%9.63K | -83.14%23.89K | -78.27%38.65K | -78.27%38.65K |
| Payables | 93.36%2.61M | -48.07%1.87M | -49.67%1.32M | 0.44%3.25M | 0.44%3.25M | -49.36%1.35M | -7.80%3.6M | -22.30%2.62M | 17.42%3.24M | 17.42%3.24M |
| -accounts payable | 93.36%2.61M | -48.07%1.87M | -49.67%1.32M | 0.44%3.25M | 0.44%3.25M | -49.36%1.35M | -7.80%3.6M | -22.30%2.62M | 17.42%3.24M | 17.42%3.24M |
| Current accrued expenses | -24.53%1.48M | 61.81%1.32M | 55.26%1.04M | 16.02%1.11M | 16.02%1.11M | 88.88%1.96M | -42.13%816.61K | -84.59%667.12K | -78.05%954.37K | -78.05%954.37K |
| Current deferred liabilities | --0 | --0 | --1M | --1M | --1M | ---- | ---- | ---- | --0 | --0 |
| Other current liabilities | 2,346.67%1.84K | 779,229,300.00%7.79M | 70,876.89%5.71M | 1,469.99%492K | 1,469.99%492K | -99.94%75 | -100.00%1 | -98.22%8.04K | -87.14%31.34K | -87.14%31.34K |
| Current liabilities | 80.56%6.65M | 162.64%13.25M | 163.62%10.34M | 46.29%6.68M | 46.29%6.68M | -12.25%3.68M | -13.75%5.04M | -54.37%3.92M | -41.69%4.57M | -41.69%4.57M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 80.56%6.65M | 162.64%13.25M | 163.62%10.34M | 46.29%6.68M | 46.29%6.68M | -12.25%3.68M | -13.89%5.04M | -54.50%3.92M | -41.98%4.57M | -41.98%4.57M |
| Shareholders'equity | ||||||||||
| Share capital | 13.38%169.03M | 13.69%159.96M | 10.38%153.04M | 9.21%150.47M | 9.21%150.47M | 8.22%149.08M | 2.36%140.71M | 0.88%138.65M | -3.93%137.78M | -3.93%137.78M |
| -common stock | 13.38%169.03M | 13.69%159.96M | 10.38%153.04M | 9.21%150.47M | 9.21%150.47M | 8.22%149.08M | 2.36%140.71M | 0.88%138.65M | -3.93%137.78M | -3.93%137.78M |
| Additional paid-in capital | 7.87%33.58M | 6.29%32.58M | 4.58%31.96M | 2.80%31.07M | 2.80%31.07M | 3.08%31.13M | 2.78%30.66M | 3.15%30.56M | 6.05%30.23M | 6.05%30.23M |
| Retained earnings | -17.10%-195.26M | -16.58%-189.94M | -13.06%-180.69M | -8.99%-172.11M | -8.99%-172.11M | -6.55%-166.75M | -4.84%-162.92M | -6.60%-159.81M | -9.53%-157.91M | -9.53%-157.91M |
| Gains losses not affecting retained earnings | -66.85%276.15K | 56.71%130.85K | -74.37%47.3K | -87.83%50.8K | -87.83%50.8K | 18.59%833.06K | -80.81%83.5K | -72.37%184.59K | -36.05%417.34K | -36.05%417.34K |
| Other equity interest | -48.50%1.03M | -57.79%1.03M | -43.65%1.38M | -26.64%2M | -26.64%2M | -25.47%2M | -24.67%2.44M | -19.41%2.45M | 27.12%2.72M | 27.12%2.72M |
| Total stockholders'equity | -46.89%8.65M | -65.65%3.76M | -52.35%5.73M | -13.27%11.48M | -13.27%11.48M | 9.80%16.29M | -29.53%10.96M | -42.32%12.03M | -56.66%13.24M | -56.66%13.24M |
| Noncontrolling interests | -21.29%-1.15M | -127.04%-1.72M | -133.43%-1.2M | -217.65%-1.04M | -217.65%-1.04M | -954.77%-944.29K | ---756.13K | ---515.55K | ---327.5K | ---327.5K |
| Total equity | -51.08%7.51M | -79.94%2.05M | -60.67%4.53M | -19.13%10.44M | -19.13%10.44M | 4.06%15.35M | -34.39%10.2M | -44.79%11.51M | -57.73%12.91M | -57.73%12.91M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"